Theravance Biopharma
TBPH
#6797
Rank
A$0.71 B
Marketcap
Country
$14.60
Share price
-1.30%
Change (1 day)
-6.86%
Change (1 year)

Theravance Biopharma (TBPH) - Cash on Hand

Cash on Hand as of June 2024 : A$0.14 Billion

According to Theravance Biopharma 's latest financial reports the company has A$0.14 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Theravance Biopharma - Cash on Hand chart (from 2013 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$0.15 B-68.76%
2022-12-31A$0.48 B101.13%
2021-12-31A$0.23 B-37.2%
2020-12-31A$0.38 B-5.02%
2019-12-31A$0.40 B-44.08%
2018-12-31A$0.71 B60.64%
2017-12-31A$0.44 B-35.77%
2016-12-31A$0.69 B193.69%
2015-12-31A$0.23 B-23.92%
2014-12-31A$0.31 B
2013-12-31N/A

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$0.18 B 24.85%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.58 B 295.86%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.68 B 360.39%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.51 B 248.68%๐Ÿ‡บ๐Ÿ‡ธ USA